Bob Goldman is speaking during the conference on a panel titled “Evaluating Damages for Misappropriation of Technical Trade Secrets.”
For more information on this event, click here.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
